MedAI Verdict
Pathology

AI Pathology

Sectra Pathology

by Sectra  ·  SE

Last verified

Digital pathology image management (Sectra IDS7) with a marketplace for third-party AI apps. Sectra does not make the AI.

Visit Sectra PathologyRead our methodology

At a glance

Pricing
No public price. Contact form only.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
—
HQ
SE
On this page

Independent score  ·  By our public rubric

25/100Niche fit
How it’s computed →
  • Regulatory & Compliance
    18/28

    FDA cleared (2 K-numbers on record)

  • Clinical Integration
    0/26

    No EHR integrations listed

  • Evidence Strength
    0/28.8

    No peer-reviewed coverage

  • Vendor & Market
    8.4/18

    Mid-tier funding and adoption

  • Sentiment & Transparency
    2.5/14

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance18/18

    FDA cleared (2 K-numbers on record)

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/14

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/4

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/21

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/8

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal8/12

    Mid-tier funding and adoption

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/9

    No clinician sentiment data available

  • Pricing transparency3/5

    Pricing on request, no public amounts

Scored October 15, 2026 · Public scoring method v1.1.0

Bottom line

Digital pathology image management (Sectra IDS7) with a marketplace for third-party AI apps. Sectra does not make the AI.

No public price. Contact form only.

Editorial review  ·  By MedAI Verdict

Bottom line

Sectra Pathology is an image management system for digital pathology: a viewer, worklists and reporting, with a marketplace for third-party AI attached. Sectra does not build the AI algorithms it lists. It fits a pathology department or hospital group that wants slide review, case management and AI apps from one vendor. In the US the Digital Pathology Module holds two FDA 510(k) clearances, the latest from April 2024. Sectra publishes no price.

What is Sectra Pathology and who sells it?

Sectra AB is a listed Swedish company based in Linköping, founded in 1978 and traded in Stockholm as SECT B. Its investor page gives net sales of SEK 3,542 million, more than 1,400 employees and customers in over 60 countries. The company runs two business lines, medical IT and cybersecurity, and the pathology product sits in the first.

The primary diagnostic application is Sectra IDS7, which Sectra describes as integrated worklists, reporting and image review. The company pitches one platform and one viewer for pathology, radiology and genomics images, so a hospital can read slides and scans in the same environment.

What does the platform cover?

The core is case navigation, worklists, reporting and image review. Sectra adds image analysis tools such as cell counting, AI-assisted workflows for cancer grading, support for DICOM and vendor-neutral whole-slide images, gross photography and radiology images. It also covers remote diagnostics, tumor boards, telepathology, research and education.

The AI arrives through Sectra Amplifier Services. Customers browse a marketplace of AI apps, buy through a single contract and have Sectra activate them. Sectra says more than 50 pathology AI vendors are integrated, that a single clinical environment can host over 100 simultaneous users, and that its platform handles more than 3 million image reviews a month. The apps themselves come from other companies, and Owkin's MSIntuit, according to Owkin, integrates with Sectra.

Which FDA clearances does it hold?

Two 510(k) clearances cover the Sectra Digital Pathology Module: K193054 from March 2020 and K232208 from April 2024 (version 3.3). Sectra also publishes a list of monitors cleared for use with the US module. The clearances belong to the viewing module, and any algorithm bought through the marketplace has its own vendor and its own regulatory status.

Sectra's older FDA record is in radiology. The FDA database lists 19 clearances under the applicant name Sectra, among them a mammography microdose system from 2011 and an image workstation from 2008.

How is it rated?

Sectra reports eight Best in KLAS awards in 2025 across radiology and digital pathology. The award count is Sectra's own statement.

What does Sectra charge?

Sectra quotes through a contact form and publishes no price or pricing model.

The verdict

Sectra Pathology makes sense as an infrastructure purchase for a lab or health system that wants to digitize slide reading under one vendor, particularly one that wants pathology and radiology images in the same viewer. A lab that is shopping for a particular cancer-grading algorithm is really choosing among the marketplace vendors, and a lab that expects Sectra to supply its own diagnostic AI will not get one.

Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

Pricing

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
Enterprise——No public price. Contact form only.

Source: vendor pricing page. Last checked October 15, 2026.

Compliance + integration

What deploys cleanly

Carries FDA 510(k) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.

In the same category

Other pathology

See the full pathology ranking